Evidence map›Paper›PMID 40888892›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample.

Yuval Kozlov, Noa Geffen, Shiri Shulman, Alon Zahavi, Orly Gal-Or, Assaf Dotan, Sivan Gazit, Tal Patalon, Amit Meshi

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuval KozlovDepartment of Military Medicine and "Tzameret", Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Noa GeffenDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Shiri ShulmanOphthalmology Institute, Assuta Medical Centers, Tel Aviv, Israel.
Alon ZahaviDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Orly Gal-OrDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Assaf DotanDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Sivan GazitMaccabi Healthcare Services, Kahn Sagol Maccabi (KSM) Research and Innovation Center, Tel Aviv, Israel.
Tal PatalonMaccabi Healthcare Services, Kahn Sagol Maccabi (KSM) Research and Innovation Center, Tel Aviv, Israel.
Amit MeshiDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel. amitmeshi@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the association between glaucoma and Parkinson's disease (PD) over an extended follow-up period and to ascertain whether the diagnosis of glaucoma increases the risk for PD development.

methodsThe anonymized electronic medical records of Israel's second largest healthcare provider were retrospectively searched for all newly diagnosed patients with glaucoma aged 40 years or older from 2000 to 2021. A total of 139,554 patients were enrolled in this study, comprising 23,259 glaucoma patients and 116,295 sex- and age-matched controls. The incidence of PD was compared between groups. The main outcome measures were the incidence rates of PD and corresponding hazard ratio (HR) for PD development among the glaucoma cohort in relation to controls. Additionally, we aimed to evaluate the impact of various confounders, comorbidities, and demographic factors on the risk of PD development in the glaucoma population.

resultsGlaucoma was not significantly associated with an increased risk of PD, with an adjusted HR of 1.145 (95% CI = 0.975-1.345). Age, male sex, and diabetes mellitus demonstrated a significant positive association with PD development in a univariate and multivariate analyses. Furthermore, the cumulative hazard log-rank test was not statistically significant (p = 0.055), suggesting no clear association between glaucoma and PD risk over the follow-up period.

conclusionThis large-scale study found no statistically significant association between glaucoma and the risk of developing PD. These findings suggest that any potential relationship is likely weak and may be influenced by confounding factors.

Indexed as

GlaucomaIntraocular PressureParkinson DiseaseAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansIncidenceIsraelMaleMiddle AgedRetrospective StudiesRisk FactorsTime FactorsGlaucomaNeurodegenerative disordersParkinson's disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.